Re-Published Medication to Manage Problematic Sexual Arousal (MMPSA) Service for the South-West, North-West and North-East regions (initial pilot service)

Organisation

NHS England

Wellington House, 133-135 Waterloo Rd, London, SE1 8UG

NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf<br/>of NHS England (referred to as the Authority), is inviting suitably qualified and<br/>experienced providers to respond to this Competitive Process for the provision of a<br/>Medication to Manage Problematic Sexual Arousal (MMPSA) Service for the South-West,<br/>North-West and North-East regions (initial pilot service) including the Clinical Regional<br/>Multi-Disciplinary Team, as part of a jointly commissioned HMPPS-NHS England care<br/>pathway.<br/><br/>The service is being commissioned under the following Lots:<br/>Lot 1 - MMPSA Service: South-West<br/>Lot 2 - MMPSA Service: North-West<br/>Lot 3 - MMPSA Service: North-East<br/><br/>MMPSA is a voluntary, clinically assessed intervention, delivered alongside psychological<br/>and behavioural support, for individuals whose problematic sexual arousal presents<br/>significant distress or risk-related concerns.<br/><br/>The service builds on an established South-West pilot and existing provision, and this<br/>procurement will both continue delivery in the South-West and expand into additional<br/>regions (North West and North East).<br/><br/>The service is at an early stage of development, following ministerial commitment as part<br/>of the sentencing review, and as such, will evolve over the contract period. Providers will<br/>be expected to deliver a safe and effective service in line with the specification, while<br/>working with Commissioners to support ongoing evaluation, learning, and refinement.<br/><br/>At a high level, the service will:<br/>* operate as a multi-disciplinary clinical service model<br/>* deliver assessment, prescribing, and ongoing medical management<br/>* integrate with wider risk management and rehabilitative services<br/>* support continuity of care across custody and (where appropriate) into the community<br/><br/>The service is due to commence in March 2027 or sooner if possible.<br/><br/>The initial contract period is 2 years with Commissioners having the option to extend for<br/>up to a further 2 years.<br/><br/>The successful Provider(s) in respect of each Lot is expected to be operational,<br/>providing some services from November/December 2026. There will be up to a 12 week mobilisation service<br/>mobilisation stage and full clinical services are expected to start in March 2027.<br/><br/>The form of contract to be entered into in respect of each Lot will be in accordance with<br/>the general NHS Standard Contract issued by the Commissioner(s), which can be found<br/>at: https://www.england.nhs.uk/nhs-standard-contract/<br/><br/>To participate in the Competitive Process, please register and access documentation via<br/>the Atamis (Health Family) portal: https://atamis-1928.my.site.com/s/Welcome<br/><br/>Should providers have any queries, or have problems using the portal, they should<br/>contact Helpdesk at: Phone: 800 9956035 E-mail: [email protected]<br/><br/>The response deadline is 12pm, midday, on Wednesday 16th September 2026 and the project<br/>reference in Atamis is C461163.<br/><br/>Activity levels and service delivery assumptions are indicative only and may vary over<br/>time; providers should design delivery models that are flexible and scalable.<br/><br/>Further detail is set out in the Service Specification.<br/><br/>This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract<br/>is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For<br/>the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not<br/>apply to this award.<br/><br/>The decision maker of the award will be: NHS England - National Commissioning Group.<br/><br/>The intention is to award a contracts using the Competitive Process.<br/><br/>The announcement by Government, on 13th March 2025, will not disrupt commissioning<br/>and contracting of this service. NHS England continues to exist as a statutory body for<br/>now. The dissolution of NHS England during the term of the contract will be subject to an<br/>act of Parliament and its undertakings will be transferred as appropriate. As and when<br/>NHS England is dissolved, commissioning responsibilities will be transferred to an<br/>alternative commissioning authority. At this time, the General Condition 12 ‘Assignment<br/>and Sub-Contracting’ of the NHS Standard Contract, as per the obligations of the<br/>commissioner, will set out the terms and conditions under which the contract will be<br/>transferred or assigned to the relevant commissioning authority.

NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf<br/>of NHS England (referred to as the Authority), is inviting suitably qualified and<br/>experienced providers to respond to this Competitive Process for the provision of a<br/>Medication to Manage Problematic Sexual Arousal (MMPSA) Service for the South-West,<br/>North-West and North-East regions (initial pilot service) including the Clinical Regional<br/>Multi-Disciplinary Team, as part of a jointly commissioned HMPPS-NHS England care<br/>pathway.<br/><br/>The service is being commissioned under the following Lots:<br/>Lot 1 - MMPSA Service: South-West<br/>Lot 2 - MMPSA Service: North-West<br/>Lot 3 - MMPSA Service: North-East<br/><br/>MMPSA is a voluntary, clinically assessed intervention, delivered alongside psychological<br/>and behavioural support, for individuals whose problematic sexual arousal presents<br/>significant distress or risk-related concerns.<br/><br/>The service builds on an established South-West pilot and existing provision, and this<br/>procurement will both continue delivery in the South-West and expand into additional<br/>regions (North West and North East).<br/><br/>The service is at an early stage of development, following ministerial commitment as part<br/>of the sentencing review, and as such, will evolve over the contract period. Providers will<br/>be expected to deliver a safe and effective service in line with the specification, while<br/>working with Commissioners to support ongoing evaluation, learning, and refinement.<br/><br/>At a high level, the service will:<br/>* operate as a multi-disciplinary clinical service model<br/>* deliver assessment, prescribing, and ongoing medical management<br/>* integrate with wider risk management and rehabilitative services<br/>* support continuity of care across custody and (where appropriate) into the community<br/><br/>The service is due to commence in March 2027 or sooner if possible.<br/><br/>The initial contract period is 2 years with Commissioners having the option to extend for<br/>up to a further 2 years.<br/><br/>The successful Provider(s) in respect of each Lot is expected to be operational,<br/>providing some services from November/December 2026. There will be up to a 12 week mobilisation service<br/>mobilisation stage and full clinical services are expected to start in March 2027.<br/><br/>The form of contract to be entered into in respect of each Lot will be in accordance with<br/>the general NHS Standard Contract issued by the Commissioner(s), which can be found<br/>at: https://www.england.nhs.uk/nhs-standard-contract/<br/><br/>To participate in the Competitive Process, please register and access documentation via<br/>the Atamis (Health Family) portal: https://atamis-1928.my.site.com/s/Welcome<br/><br/>Should providers have any queries, or have problems using the portal, they should<br/>contact Helpdesk at: Phone: 800 9956035 E-mail: [email protected]<br/><br/>The response deadline is 12pm, midday, on Wednesday 16th September 2026 and the project<br/>reference in Atamis is C461163.<br/><br/>Activity levels and service delivery assumptions are indicative only and may vary over<br/>time; providers should design delivery models that are flexible and scalable.<br/><br/>Further detail is set out in the Service Specification.<br/><br/>This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract<br/>is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For<br/>the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not<br/>apply to this award.<br/><br/>The decision maker of the award will be: NHS England - National Commissioning Group.<br/><br/>The intention is to award a contracts using the Competitive Process.<br/><br/>The announcement by Government, on 13th March 2025, will not disrupt commissioning<br/>and contracting of this service. NHS England continues to exist as a statutory body for<br/>now. The dissolution of NHS England during the term of the contract will be subject to an<br/>act of Parliament and its undertakings will be transferred as appropriate. As and when<br/>NHS England is dissolved, commissioning responsibilities will be transferred to an<br/>alternative commissioning authority. At this time, the General Condition 12 ‘Assignment<br/>and Sub-Contracting’ of the NHS Standard Contract, as per the obligations of the<br/>commissioner, will set out the terms and conditions under which the contract will be<br/>transferred or assigned to the relevant commissioning authority.

NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf<br/>of NHS England (referred to as the Authority), is inviting suitably qualified and<br/>experienced providers to respond to this Competitive Process for the provision of a<br/>Medication to Manage Problematic Sexual Arousal (MMPSA) Service for the South-West,<br/>North-West and North-East regions (initial pilot service) including the Clinical Regional<br/>Multi-Disciplinary Team, as part of a jointly commissioned HMPPS-NHS England care<br/>pathway.<br/><br/>The service is being commissioned under the following Lots:<br/>Lot 1 - MMPSA Service: South-West<br/>Lot 2 - MMPSA Service: North-West<br/>Lot 3 - MMPSA Service: North-East<br/><br/>MMPSA is a voluntary, clinically assessed intervention, delivered alongside psychological<br/>and behavioural support, for individuals whose problematic sexual arousal presents<br/>significant distress or risk-related concerns.<br/><br/>The service builds on an established South-West pilot and existing provision, and this<br/>procurement will both continue delivery in the South-West and expand into additional<br/>regions (North West and North East).<br/><br/>The service is at an early stage of development, following ministerial commitment as part<br/>of the sentencing review, and as such, will evolve over the contract period. Providers will<br/>be expected to deliver a safe and effective service in line with the specification, while<br/>working with Commissioners to support ongoing evaluation, learning, and refinement.<br/><br/>At a high level, the service will:<br/>* operate as a multi-disciplinary clinical service model<br/>* deliver assessment, prescribing, and ongoing medical management<br/>* integrate with wider risk management and rehabilitative services<br/>* support continuity of care across custody and (where appropriate) into the community<br/><br/>The service is due to commence in March 2027 or sooner if possible.<br/><br/>The initial contract period is 2 years with Commissioners having the option to extend for<br/>up to a further 2 years.<br/><br/>The successful Provider(s) in respect of each Lot is expected to be operational,<br/>providing some services from November/December 2026. There will be up to a 12 week mobilisation service<br/>mobilisation stage and full clinical services are expected to start in March 2027.<br/><br/>The form of contract to be entered into in respect of each Lot will be in accordance with<br/>the general NHS Standard Contract issued by the Commissioner(s), which can be found<br/>at: https://www.england.nhs.uk/nhs-standard-contract/<br/><br/>To participate in the Competitive Process, please register and access documentation via<br/>the Atamis (Health Family) portal: https://atamis-1928.my.site.com/s/Welcome<br/><br/>Should providers have any queries, or have problems using the portal, they should<br/>contact Helpdesk at: Phone: 800 9956035 E-mail: [email protected]<br/><br/>The response deadline is 12pm, midday, on Wednesday 16th September 2026 and the project<br/>reference in Atamis is C461163.<br/><br/>Activity levels and service delivery assumptions are indicative only and may vary over<br/>time; providers should design delivery models that are flexible and scalable.<br/><br/>Further detail is set out in the Service Specification.<br/><br/>This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract<br/>is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For<br/>the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not<br/>apply to this award.<br/><br/>The decision maker of the award will be: NHS England - National Commissioning Group.<br/><br/>The intention is to award a contracts using the Competitive Process.<br/><br/>The announcement by Government, on 13th March 2025, will not disrupt commissioning<br/>and contracting of this service. NHS England continues to exist as a statutory body for<br/>now. The dissolution of NHS England during the term of the contract will be subject to an<br/>act of Parliament and its undertakings will be transferred as appropriate. As and when<br/>NHS England is dissolved, commissioning responsibilities will be transferred to an<br/>alternative commissioning authority. At this time, the General Condition 12 ‘Assignment<br/>and Sub-Contracting’ of the NHS Standard Contract, as per the obligations of the<br/>commissioner, will set out the terms and conditions under which the contract will be<br/>transferred or assigned to the relevant commissioning authority. Additional information: There is an option to extend for up to a further 2 years following the initial contract period, subject to performance and further funding.

Document pack· 1 file

2,057

total contracts

£178442.5m

total value

£252,751,486

average contract size